23/08/2026
On July 31, 2026, the AmCham Philippines Pharmaceutical Committee convened a high-level stakeholder roundtable at Robert Sears Hall in Makati to advance comprehensive strategies for strengthening lung cancer prevention, early detection, treatment access, and patient-centered care. Moderated by Pharmaceutical Committee Co-chairs Mr. Martin Crisostomo and Rachel Queenie Dizon-Rodulfo, the session featured keynote speaker Dr. Mary Bussell (CEO, TriMar Strategies) who shared international best practices and critical policy interventions, alongside Engr. Emerito "Emer" Rojas (President, Lung Health Alliance of the Philippines), who provided invaluable perspective as both a cancer survivor and patient advocate. The dialogue reinforced a shared commitment: addressing a critical health challenge in which lung cancer remains one of the Philippines' leading causes of cancer-related mortality.
We are grateful for the active participation and commitment of our distinguished attendees representing Johnson & Johnson, AstraZeneca, Fullerton Health & Radlink, Makati Health Department, PhilCare, Wells Fargo, and AIM. This collaborative engagement strengthened public-private partnerships and generated concrete actionable recommendations to foster equitable access to innovative diagnostics and therapies, build institutional capability, and drive measurable improvements in lung cancer outcomes for all Filipino patients.